ir.amagpharma.com
Investors : Investors : AMAG PharmaceuticalsInvestor information for AMAG Pharmaceuticals
http://ir.amagpharma.com/
Investor information for AMAG Pharmaceuticals
http://ir.amagpharma.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
16x16
PAGES IN
THIS WEBSITE
1
SSL
EXTERNAL LINKS
20
SITE IP
184.51.0.218
LOAD TIME
0 sec
SCORE
6.2
Investors : Investors : AMAG Pharmaceuticals | ir.amagpharma.com Reviews
https://ir.amagpharma.com
Investor information for AMAG Pharmaceuticals
ir.amagpharma.com
Press Release – Investors – AMAG Pharmaceuticals
http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-newsArticle&id=2047752
AMAG Pharmaceuticals, Inc. to Participate in the UBS Global Healthcare Conference. May 13, 2015. AMAG Pharmaceuticals, Inc. Nasdaq:AMAG) today announced that. AMAG's chief executive officer, will present at the. UBS Global Healthcare Conference. Monday, May 18, 2015. The session will include a company presentation followed by a question and answer session, in which the company's financial results, business update, and growth prospects will be discussed. AMAG Pharmaceuticals, Inc. Website for 30 days.
TOTAL PAGES IN THIS WEBSITE
1
Our Products – AMAG Pharmaceuticals
http://www.amagpharma.com/products/mugard
Research & Growth. Our products support the health of patients in the areas of maternal health, anemia management and cancer supportive care. We also help families preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders, and have the potential to play a valuable role in the ongoing development of regenerative medicine. Indication and Important Safety Information. Newborn stem cell preservation through Cord Blood Registry.
Research & Growth – AMAG Pharmaceuticals
http://www.amagpharma.com/collaborations
Research & Growth. Clinical Research for Existing Products. Research & Growth. We recognize the immense value of clinical research and are committed to investing in it to expand the body of knowledge in our therapeutic areas and advance potential future health innovations for patients. Clinical Research for Existing Products. Too many patients and families continue to experience the effects of serious health conditions that have no currently available treatments or cures. More. Research & Growth.
Our Products – AMAG Pharmaceuticals
http://www.amagpharma.com/products/feraheme
Research & Growth. Our products support the health of patients in the areas of maternal health, anemia management and cancer supportive care. We also help families preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders, and have the potential to play a valuable role in the ongoing development of regenerative medicine. Indication and Important Safety Information. Newborn stem cell preservation through Cord Blood Registry.
Contact & Locations – AMAG Pharmaceuticals
http://www.amagpharma.com/us/directions
Research & Growth. Contact & Locations. Contact & Locations. AMAG Pharmaceuticals, Inc. Waltham, MA 02451. 6550 S. Bay Colony Drive, #160. Tucson, AZ 85756. 1200 Bayhill Drive, 3rd Floor. San Bruno, CA 94066. Drug Information and Adverse Event Reporting. International callers: 650.635.1420. Research & Growth.
About Us – AMAG Pharmaceuticals
http://www.amagpharma.com/us
Research & Growth. Contact & Locations. Download Our Corporate Brochure. Our promise: Every day the people at AMAG aim higher, devoting our passion and perseverance to finding new and better ways to support the health of patients and families. AMAG is a biopharmaceutical company focused on bringing therapeutics to market that provide clear benefits and help improve people’s lives. Our Corporate Growth Strategy:. Our current products through meaningful investment in research to expand the utility of these...
Our Commitment – AMAG Pharmaceuticals
http://www.amagpharma.com/community
Research & Growth. To Patients, Families and Providers. We are in constant pursuit of new and better ways to help support patients and families along the path to health. We strive to put patients and their families at the center of everything we do. It starts by understanding their needs and the needs of the providers who care for them. This understanding shapes our approach to delivering therapeutics and comprehensive support to the people we serve. To Patients, Families and Providers.
About Us – AMAG Pharmaceuticals
http://www.amagpharma.com/careers/values-and-culture
Research & Growth. Contact & Locations. Download Our Corporate Brochure. Our promise: Every day the people at AMAG aim higher, devoting our passion and perseverance to finding new and better ways to support the health of patients and families. AMAG is a biopharmaceutical company focused on bringing therapeutics to market that provide clear benefits and help improve people’s lives. Our Corporate Growth Strategy:. Our current products through meaningful investment in research to expand the utility of these...
Board of Directors – AMAG Pharmaceuticals
http://www.amagpharma.com/us/board-of-directors
Research & Growth. Contact & Locations. Our board members have extensive experience in the pharmaceutical industry, and their guidance helps us bring important therapeutics to patients in need. Former Executive Vice President and Chief Corporate Development Officer of Shire plc. Barbara Deptula has been a director since September 2013. Ms. Deptula brings to the AMAG board broad-based corporate development expertise obtained through her distinguished 30-year career in a. John A. Fallon, M.D. Robert Perez ...
Our Products – AMAG Pharmaceuticals
http://www.amagpharma.com/products
Research & Growth. Our products support the health of patients in the areas of maternal health, anemia management and cancer supportive care. We also help families preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders, and have the potential to play a valuable role in the ongoing development of regenerative medicine. Indication and Important Safety Information. Newborn stem cell preservation through Cord Blood Registry.
Leadership Team – AMAG Pharmaceuticals
http://www.amagpharma.com/us/leadership-team
Research & Growth. Contact & Locations. Our senior management team’s leadership and vision are critical to the company’s operational efficiency and growth, positioning us well to continue bringing important therapeutics to patients in need. William K. Heiden. William Heiden is an experienced pharmaceutical and biotechnology executive who has been chief executive officer of AMAG since May 2012 and. Frank E. Thomas. President and Chief Operating Officer. Senior Vice President, Human Resources. Julie Krop, ...
TOTAL LINKS TO THIS WEBSITE
20
Alpha Natural Resources
Our Products and Services. The Story of Coal. Running Right Safety Process. Running Right Leadership Academy. What's It Like to Work at Alpha? Key Statistics and Ratios. PLR Minimum Capex Guidance. Overview of Certain Property. Foreign Affiliates, Joint Ventures and Partnerships. As of August 14, 2015 -. Minimum 20 minute delay. Alpha Natural Resources Announces Voluntary Chapter 11 Restructuring to Position Itself for Future Viability in Challenged Coal Markets. Alpha Natural Resources Affiliates Issue ...
Investor Relations - Altisource Portfolio Solutions
Altisource Investor Relations is committed to providing helpful and timely information to our shareholders and encourage you to utilize this site for more detailed investor relations information. Find timely information for shareholders here or contact us directly. Mar 5, 2018. Lenders One Celebrates the Largest Number of New Members in its 18-Year History. SCOTTSDALE, AZ - (Marketwired) - 03/05/18 - The Lenders One Cooperative, a national alliance of independent mortgage bankers, today announced.
Altisource Asset Management - Shareholders
Historic Share Price Lookup. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Altisource Asset Management's financial performance into perspective. View all ». Aug 10, 2015. Altisource Asset Management Corporation Reports Second Quarter 2015 Results. Jul 29, 2015. Altisource Asset Management Corporation Schedules Conference Call for Second Quarter 2015 Results. 4:01 PM ET on Aug 14, 2015.
Altisource Residential Corporation - Shareholders
Aug 14, 2015. Delayed at least 20min., by eSignal. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Altisource Residential Corporation's financial performance into perspective. View all ». Aug 11, 2015. Altisource Residential Corporation Announces $100 Million Stock Repurchase Program. Aug 10, 2015. Altisource Residential Corporation Reports Second Quarter 2015 Results. Christiansted, VI 00820-3531.
Investor Relations | Altra Industrial Motion Corp.
Skip to main navigation. Electric Clutches and Brakes. Electric Clutches and Brakes. Couplings, Clutches and Brakes. Heavy Duty Clutches and Brakes. Annual Reports and Proxies. Annual Reports and Proxies. Altra is a leading global designer, producer and marketer of a wide range of mechanical power transmission components. With a strong long-term focus on Operational Excellence, organic growth and strategic acquisitions, Altra strives to create superior value for our customers, shareholders and associates.
Investors : Investors : AMAG Pharmaceuticals
Q2 2015 AMAG Pharmaceuticals, Inc. Earnings Conference Call. 160;at 8:00 am ET. AMAG 2Q 2015 Financial Results Presentation. Is committed to improving the health outcomes of patients through the development and commercialization of specialty pharmaceutical products. Vice President, Investor Relations and Corporate Communications. 2015 AMAG Pharmaceuticals Inc.
Amara Holdings Limited - Investor Relations
HOTEL INVESTMENT and MANAGEMENT. PROPERTY INVESTMENT and DEVELOPMENT. SPECIALTY RESTAURANTS and FOOD SERVICES. Stock Quote (SES: A34). 4:51 PM ET on Aug 14, 2015. Delayed at least 20 minutes. View all ». Aug 12, 2015. Financial Statements and Related Announcement: Second Quarter and/ or Half Yearly. Aug 5, 2015. Disclosure of Interest/Changes in Interest of Substantial Shareholder(s)/Unitholder(s). View all ». Jan 10, 2015.
Investors :: Amarantus BioScience Holdings, Inc. (AMBS)
Amarantus BioScience Holdings, Inc. Email Alerts. Amarantus BioScience Holdings, Inc. on Facebook. Amarantus BioScience Holdings, Inc. on LinkedIn. Amarantus BioScience Holdings, Inc. on Twitter. Amarantus BioScience Holdings, Inc. on GooglePlus. Amarantus BioScience Holdings, Inc. RSS. Alzheimer's Disease Diagnostics SAB. Download our latest investor presentation. Aug 8, 2016. Mar 31, 2016. The company’s diagnostics division, Amarantus Diagnostics is dedicated to the development and commercializat...
Investor Overview | Investor Relations | A-Mark Precious Metals - Gold, Silver and Platinum - Charts, Graphs, Spot Prices, London fix, New York close
Press "Enter" to Search. Our trading desk is open 17 hours from 12:00am to 5:00pm PST. CEO Interview - Click Here. Data as of 08/14/15 3:38 pm ET. Annual Meeting and Proxy Information. To access this year's proxy statement. A-Mark Precious Metals Appoints Grant Thornton as Independent Auditor. A-Mark Precious Metals Joins the Fortune 500. A-Mark Precious Metals to Present at the LD Micro Invitational on June 3, 2015. A-Mark Precious Metals Inc at Liolios Group 4th Annual Gateway Conference. Replication o...
Investor Relations | Ambac Financial Group, Inc.
Skip to main navigation. Detailed Schedule of Insurance Exposures. Assets held in Ambac Sponsored MTN Conduits. Largest Domestic Public Finance Exposures. Largest Structured Finance Exposure. Investment Schedule for AAC and Everspan. Investment Schedule for AUK. Segregated Account Payments and Obligations. Annual Meeting of Stockholders. 8:46 PM on Mar 29, 2018. Mar 08, 2018. Ambac Announces Annual Meeting on May 18, 2018. Mar 05, 2018. Ambac to Participate in BTIG's Financial Guarantors Conference.
Ambev
Saturday, august 15, 2015. Guide to Our Business. ADR Program for Foreign Investors. Annual and Sustainability Report. Controlling shareholders Shareholders Agreement. Differences between U.S. and Brazilian corporate governance practices. Results - Excel Charts 2Q15. To give your opinion about our website. Is a format of Internet news distribution, such as Ambev's. News and Announcements. By using RSS. You get to know immediately when any information that interests you is published. You must have a RSS.
